Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
May 01, 2024 08:47 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications ...
Europe DNA/RNA Sample Extraction and Isolation Research Report 2024: A $1.23 Billion Market by 2033, Driven by Rising Demand for Genomic Analysis in Research, Diagnostics, and Forensic Applications
April 30, 2024 10:49 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Europe DNA/RNA Sample Extraction and Isolation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. ...
Global RNA Analysis Market Forecast, 2028: Rising RNA-Seq Data Volume Spurs Demand for Advanced Bioinformatics Tools, Enhanced Algorithms Key in Harnessing Genetic Insights
April 19, 2024 10:42 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "RNA Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
microRNA (miRNA) Global Strategic Business Report 2024-2030: Increasing Investments and Focus on Development of miRNA-based Therapeutics Bodes Well for Market Growth
April 18, 2024 07:16 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "microRNA (miRNA) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global microRNA (miRNA) Market to...
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15, 2024 09:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
Global MicroRNA Market Exhibits Impressive Growth with a 12.20% CAGR through 2028
April 12, 2024 10:12 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
March 28, 2024 08:30 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
Global gRNA Research Analysis Report 2024: Precision in Gene Editing and Rising Adoption of NGS Technologies Enhancing gRNA Applications
March 13, 2024 11:55 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type...
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
March 11, 2024 09:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment